|
Abstract Submission is now CLOSED.
Click on the link below to go directly to this section:
The Program Planning Committee invites abstracts in the areas of Basic Science, Clinical Science, Epidemiology and Public Health, and Social Sciences. Abstracts may be submitted and presented in either English or French. There is a limit of two abstract submissions per presenting author. On the abstract submission form we are asking authors to indicate whether you feel your abstract would have some overlap with another conference track. This will help the organizers plan sessions that are trans-disciplinary. The abstract submission deadline is January 18, 2010.
Abstracts received after this date will not be reviewed.
Scholarships and New Investigator Awards will be presented to eligible candidates. For application details, visit the Academic Scholarship, Community Scholarship or New Investigator Awards pages.
Abstract Guidelines
Submission of an abstract acknowledges your consent to the following:
- If accepted, your abstract may be published in a medical publication.
- Agree to prepare a "one-page media profile sheet" on your abstract for distribution to media if requested by CAHR 2010.
- Agree to allow Rapporteurs to use all or part of your presentation or poster in the Rapporteur presentation at CAHR 2010. The Rapporteur presentation will not be made available for public presentation or downloading.
Abstracts should be no more than 300 words in length, not including the title. Please note that abstracts will be truncated at 300 words in the Journal if they run longer.
Prepare your abstract in Wordprocessing software such as MS Word, WordPerfect, or a text editor such as MS Write. Do not use presentation software such as PowerPoint. Your abstract should be in English or French, and will be published in the language of submission. If you incorporate a data table in your abstract, the table counts as 50 words against your 300 word total.
The abstract submission deadline is January 18, 2010. The results of the peer review are expected to be available early March 2010. The submitting author will be notified by email. Subsequent correspondence will be with the presenting author(s).
Back to Top
Policy on Disclosure of Potential Conflicts of Interest
If, within the past five years, an author or immediate family member has had a substantial personal financial relationship relating to the support of the abstract, this relationship must be described. Such relationships include salaries, ownerships, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support and other financial arrangements. During the abstract submission process you will be asked to disclose any potential conflicts of interest.
For more information on the full CAHR Policy on Disclosure of Potential Conflicts of Interest, please click here.
Back to Top
CAHR Policies on Abstract Submission and Acceptance
These policies on abstract submission and acceptance are intended to provide guidance for oral sessions and posters for the annual Canadian conferences on HIV/AIDS research.
Policy Statement: Scientific abstracts submitted for CAHR conference program should demonstrate a clear Canadian connection.
“Canadian connection” would include, but not be limited to, the following criteria as general guidelines. To demonstrate a Canadian connection, an abstract would need to meet at least one or more of these criteria.
- one or more investigators are based in Canada, are Canadian residents or trained in Canada
- one or more funders are based in Canada, i.e. a Canadian funder, or other national or international funder (organization or individual) that is based in or operating in Canada
- one or more Canadian scientific research or other organizations based in Canada is involved or partnered in the research project
- at least some of the research population is resident in Canada
- at least some of the research activity is conducted in Canada
- the research builds extensively on existing Canadian research
- the evidence from the research is relevant, wholly or partially, to current issues and challenges specific to the HIV/AIDS response in Canada
- other connection such as the research was initiated, proposed or promoted by Canadian researcher(s) or institution(s).
Policy Statement: This policy is tended to support the broadest number of researchers to participate in the Conference program. Any researcher, who is submitting an abstract or presenting an oral session or an abstract poster, must be a member of the research or investigation team. Researchers are limited to presenting two abstracts per researcher during the Conference program (including oral sessions and abstract posters). Abstracts may be submitted by other researchers on the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the Conference program, that researcher may be listed as the presenter only twice (oral session or abstract poster).
Exceptions to this policy may be considered on a case-by-case basis where in the opinion of the Track Chair and/or Conference Organizing Committee, such an exception may enhance the Conference program and/or advance HIV research and/or knowledge exchange. All decisions of the Conference Organizing Committee are final.
Presenting Author Registration Information
Presenting Authors must register to attend the CAHR 2010 Conference. If you are not registered by the Presenting Author registration deadline your abstract may not be included in the final program.
Take advantage of early bird conference rates by visiting the Registration section of the CAHR 2010 Website. The Presenting Author registration deadline is Wednesday, March 24, 2010.
Back to Top
Abstract Subjects for CAHR 2010
Basic Sciences
- HIV Structure, Function and Genetics
- Pathogenesis and Cell Biology of HIV Infection and Co-infection
- Innate and Adaptive Immune Responses to HIV Infection and Co-Infection
- Molecular Epidemiology of HIV and the Influence of Host Factors on Drug Resistance, Immune Evasion and Viral Evolution
- Anti-retroviral Drugs, Microbicides, and Vaccines (Preclinical)
Clinical Sciences
- ARV clinical trials and other ARV studies
- Issues in women and children
- Prevention, Natural History, and Monitoring
- Other complications of HAART
- CVD and other issues in the aging population
- Resistance
- Adherence
- HIV Prevention
- HIV Therapies
- Co-infections (including HCV, HBV, HPV, syphilis, TB)
- Pharmacology and pharmacokinetics
- Issues in the developing world and vulnerable
Epidemiology and Public Health
- Epidemiology of HIV/AIDS
- Methodological Issues and Capacity-Building in Epidemiological and Prevention Research
- Epidemiology of co-infection (HCV/HIV, TB and syphilis)
- Evaluation of Behavioural and Biomedical Interventions to Prevent HIV
- HIV/AIDS Surveillance, Monitoring and Evaluation, Mathematical Modelling
- Prevention Programmes
Social Sciences
- Advances in Social Research Methods and Theories in HIV
- Social Structural and Population-level Risks and Interventions to Prevent HIV
- Individual-level/behavioural Risks and Interventions to Prevent HIV
- Policy and Social, Political, and Legal Aspects of HIV
- HIV Treatment and Care
- Living with HIV
Back to Top
Submit Your Abstract
Abstract Submission is closed.
Back to Top
Questions?
Please email your questions on abstract submission to techsupport@scolars.com.
|
